IP Library Granted Patent US 7,544,767
Granted Patent B2
US 7,544,767 · App. 10/400,083 · Granted Jun 9, 2009

HMGN2 peptides and related molecules that selectively home to tumor blood vessels and tumor cells

Assignee: Burnham Institute for Medical Research
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,544,767
App. No.
10/400,083
Granted
Jun 9, 2009
Kind
B2
Abstract

The present invention provides a conjugate which contains a therapeutic moiety linked to a homing molecule that selectively homes to tumor blood vessels and tumor cells and that specifically binds the receptor bound by peptide KDEPQRRSARLSAKPAPPKPEPKPKKAPAKK (SEQ ID NO: 9). Methods of directing a conjugate of the invention to tumor blood vessels and tumor cells and of using a conjugate to treat cancer also are provided.

Claims (15)

1. An isolated homing peptide comprising the amino acid sequence KDEPQRRSARLSAKPAPPKPEPKPKKAPAKK (SEQ ID NO: 9) said peptide having a length of less than 70 residues, wherein said peptide specifically binds nucleolin expressed on the surface of a tumor cell.

2. The isolated peptide of claim 1 , which has a length of less than 60 residues.

3. The isolated peptide of claim 1 , which has a length of less than 50 residues.

4. The isolated peptide of claim 1 , which has a length of less than 45 residues.

5. The isolated peptide of claim 1 , which has a length of less than 40 residues.

6. The isolated peptide of claim 1 , which has a length of less than 35 residues.

7. An isolated homing peptide that selectively homes to tumor blood vessels or tumor cells, comprising the amino acid sequence KDEPQRRSARLSAKPAPPKPEPKPKKAPAKK (SEQ ID NO: 9), said peptide having a length of less than 70 residues.

8. The isolated homing peptide of claim 7 , which has a length of less than 60 residues.

9. The isolated homing peptide of claim 7 , which has a length of less than 50 residues.

10. The isolated homing peptide of claim 7 , which has a length of less than 45 residues.

11. The isolated homing peptide of claim 7 , which has a length of less than 40 residues.

12. The isolated homing peptide of claim 7 , which has a length of less than 35 residues.

13. An isolated peptide consisting of the amino acid sequence KDEPQRRSARLSAKPAPPKPEPKPKKAPAKK (SEQ ID NO: 9).

14. A chimeric polypeptide comprising a peptide consisting of the amino acid sequence KDEPQRRSARLSAKPAPPKPEPKPKKAPAKK (SEQ ID NO: 9) fused to a heterologous polypeptide, wherein said chimeric polypeptide specifically binds nucleolin.

15. A chimeric polypeptide comprising a peptide consisting of the amino acid sequence KDEPQRRSARLSAKPAPPKPEPKPKKAPAKK (SEQ ID NO: 9) fused to a heterologous polypeptide, wherein said chimeric polypeptide selectively homes to tumor blood vessels or tumor cells.

Assignments (5)
CHANGE OF NAME Recorded Jan 2, 2020
From: SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE
To: SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
Reel/Frame 051460/0435 →
CHANGE OF NAME Recorded Nov 10, 2010
From: BURNHAM INSTITUTE FOR MEDICAL RESEARCH
To: SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE
Reel/Frame 025346/0702 →
CHANGE OF NAME Recorded Sep 12, 2008
From: THE BURNHAM INSTITUTE
To: BURNHAM INSTITUTE FOR MEDICAL RESEARCH
Reel/Frame 021524/0849 →
CONFIRMATORY LICENSE Recorded Jun 4, 2008
From: THE BURNHAM INSTITUTE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021037/0530 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 19, 2003
From: RUOSLAHTI, ERKKI; PORKKA, KIMMO; CHRISTIAN, SVEN
To: BURNHAM INSTITUTE, THE
Reel/Frame 013748/0415 →
Continuity (2)
Provisional Application 6045370600 · Apr 5, 2002
Related Publication 20040186056A1 · Sep 23, 2004